Frontiers in Cancer Science—the Singapore Cancer Conference
Guest post by Patrick Casey, PhD, and Joanne Ngeow, BMedSci, MBBS, FRCP, MPH
From November 7-9, 2022, Singapore will hold its 14th Frontiers in Cancer Science (FCS) conference at the Lee Kong Chian School of Medicine, Nanyang Technological University Singapore. This annual conference started in 2009 as a one-day symposium for the common purpose of sharing and advancing knowledge both locally as well with the global scientific community. It has now grown into a major international cancer conference in the region, with over 500 participants registering annually.
FCS is the largest cancer conference in Singapore and regularly brings together cancer researchers and cancer physicians to share their pioneering ideas and novel information in an interactive environment that fosters collaboration. Highlights of the previous FCS conferences can be seen on the conference website. For the past two years, due to the global COVID-19 pandemic, FCS 2020 and 2021. were held virtually. Together, the conferences welcomed close to 1,200 registrants from more than 50 countries, including Australia, China, India, Malaysia, Japan, the United States, and Great Britain. We are happy that FCS 2022 will be an in-person conference.
This year’s meeting will feature a stellar list of international and local distinguished cancer researchers with complementary knowledge and expertise across all aspects of cancer research. Advances in both the basic science and the clinical realms will be presented. There will also be the opportunity for young investigators to showcase their work, and selected talks from poster abstracts will be presented at the Oral Abstract Speaker Sessions during the conference. Prizes will also be awarded for the best posters, including two travel awards (each worth $2,500) for two meritorious poster presentations to support travel to the American Association for Cancer Research (AACR) Annual Meeting 2023.
Since 2020, FCS has been honored to partner with AACR to concurrently hold the AACR-FCS Education Sessions—the first in Southeast Asia. These education sessions have been highly successful, with many of our participants benefiting from the talks. The goal of the education sessions is to provide graduate students and early-career investigators with a broader view of selected subject matters, presented by key opinion leaders. Speakers for 2022 AACR-FCS Education Sessions include Matthew Vander Heiden, MD, PhD, from the Koch Institute at Massachusetts Institute of Technology, who will discuss how metabolism affects cancer progression; Joseph Sung, MD, PhD, from the Lee Kong Chian School of Medicine at Nanyang Technological University Singapore, who will discuss colorectal cancer screening and post-polypectomy surveillance; and Antonio Bertoletti, MD, from Duke-NUS, who will discuss how immunology can inform cancer therapy.
FCS is jointly organized by the Cancer Science Institute of Singapore, Duke-NUS Medical School, Genome Institute of Singapore, Institute of Molecular and Cell Biology, Lee Kong Chian School of Medicine, National Cancer Centre Singapore, National University Cancer Institute, Singapore, and Yong Loo Lin School of Medicine. You can find the program highlights for this exciting international conference, as well as information about registration on the conference website.
Patrick Casey, PhD, and Joanne Ngeow, BMedSci, MBBS, FRCP, MPH, are cochairs of this year’s Frontiers in Cancer Science conference. Casey is the senior vice dean of Research at the Duke-NUS Medical School. He is also a James B. Duke Professor of Pharmacology and Cancer Biology at the Duke University. Ngeow is an associate professor of genomic medicine at the Lee Kong Chian School of Medicine, Nanyang Technological University Singapore and Senior Consultant, Division of Medical Oncology at the National Cancer Centre Singapore (NCCS). Ngeow currently heads the Cancer Genetics Service at the NCCS.
